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Background: Improved primary health care is needed in developing countries to effectively manage the growing
burden of hypertension. Our objective was to evaluate hypertension management in Zambian rural primary care
clinics using process and outcome indicators to assess the screening, monitoring, treatment and control of high
blood pressure.
Methods: Better Health Outcomes through Mentoring and Assessment (BHOMA) is a 5-year, randomized stepped-
wedge trial of improved clinical service delivery underway in 46 rural Zambian clinics. Clinical data were collected
as part of routine patient care from an electronic medical record system, and reviewed for site performance
over time according to hypertension related indicators: screening (blood pressure measurement), management
(recorded diagnosis, physical exam or urinalysis), treatment (on medication), and control. Quantitative data
was used to develop guides for qualitative in-depth interviews, conducted with health care providers at a
proportional sample of half (20) of clinics. Qualitative data was iteratively analyzed for thematic content.
Results: From January 2011 to December 2014, 318,380 visits to 46 primary care clinics by adults aged≥ 25 years with
blood pressure measurements were included. Blood pressure measurement at vital sign screening was initially high at 89.
1% overall (range: 70.1–100%), but decreased to 62.1% (range: 0–100%) by 48 months after intervention start. The majority
of hypertensive patients made only one visit to the clinics (57.8%). Out of 9022 patients with at least two visits with an
elevated blood pressure, only 49.3% had a chart recorded hypertension diagnosis. Process indicators for monitoring
hypertension were <10% and did not improve with time. In in-depth interviews, antihypertensive medication shortages
were common, with 15/20 clinics reporting hydrochlorothiazide-amiloride stockouts. Principal challenges in hypertension
management included 1) equipment and personnel shortages, 2) provider belief that multiple visits were needed before
official management, 3) medication stock-outs, leading to improper prescriptions and 4) poor patient visit attendance.
Conclusions: Our findings suggest that numerous barriers stand in the way of hypertension diagnosis and management
in Zambian primary health facilities. Future work should focus on performance indicator development and validation in
low resource contexts, to facilitate regular and systematic data review to improve patient outcomes.
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Globally, noncommunicable diseases (NCD) are the
leading cause of death, resulting in greater mortality
than every other cause combined. Almost 80% of
NCD deaths occur in low and middle income coun-
tries (LMIC), with cardiovascular diseases (CVD)
claiming the greatest percentage [1, 2]. In Zambia,
NCDs accounted for 23% of total deaths in 2008,
and is expected to grow rapidly in the coming de-
cades as the country continues the epidemiological
transition [2]. There is increasing evidence that a
robust primary care system can not only handle the
growing NCD burden, but also manage risk factors
like hypertension for CVD, to prevent disease pro-
gression [3, 4].
In this context, performance monitoring is critical
to develop, support and sustain effective delivery of
proven therapies in primary care for NCDs. Quality
improvement provides an iterative framework to
monitor multilevel contributors to patient outcomes
by using routine health program data to examine
what system elements need to be changed [5, 6].
Measurable performance markers are broken down
into indicators examining structure (physical facility),
process (diagnosis and treatment) and outcome (mor-
tality, recovery) indicators [7, 8]. When linked with
pay for performance, indicators accelerate improve-
ments in quality in both developed and developing
settings [9, 10].
Existing performance indicators for hypertension
were developed in North America and Europe
through a modified Delphi process at the national
level, with expert panel review of the scientific litera-
ture and evaluation for feasibility [11–14]. In the
United States, assessments based on 28 process indi-
cators for hypertension showed that only 57% of
patients received optimal care, and higher quality care
as evidenced by the indicators was associated with a
higher likelihood of blood pressure control [11].
Unfortunately, no formal process for creating and val-
idating performance indicators currently exists in
Zambia, although there is growing interest in quality
improvement [15, 16]. Indicators from the United
States or the United Kingdom are not directly applic-
able to developing countries, where feasibility of indi-
cator measurement may be drastically different. There
exists a need to develop locally appropriate quality
improvement indicators.
This paper presents data on novel retrospectively gen-
erated process and outcome indicators for hypertension
management, informed by those from Western coun-
tries, but adapted to the Zambian primary care clinics
enrolled in the Better Health outcomes through Mentor-
ing and Assessment (BHOMA) study.Methods
Study setting and design
Better Health Outcomes through Mentoring and Assess-
ment (BHOMA) is a 5-year, randomized stepped-wedge
trial of improved clinical service delivery underway in 46
rural government clinics in Chongwe, Kafue and
Luangwa districts of Zambia, which represent almost all
publically run rural clinics in Lusaka province. As such,
they capture the full range of size, patient population
and services available in rural Zambian government
primary care clinics. Many rural clinics are staffed by a
single nurse or clinical officer, and have frequent equip-
ment or medication shortages. BHOMA aims to im-
prove primary healthcare through use of standardized
protocols for common visits, onsite electronic medical
records (EMR), and ongoing mentoring to improve key
indicators [17]. BHOMA began with pilot sites in Aug
2010, with the EMR operational starting Jan 2011; thus
all data from Jan 2011 to Dec 2014 are included here.
District based Quality Improvement teams of 5–8 spe-
cially trained nurses and clinical officers make regular
visits at participating clinics for mentoring meetings,
record review and general support. Community volun-
teers were also trained to perform non-specialist tasks as
clinic support workers, including patient file manage-
ment and vital signs. We used an explanatory sequential
design by conducting a quantitative analysis, which was
then explained through a qualitative follow up
component.
Study subjects
For the quantitative component, all visits by patients
aged ≥25 years across all 46 health facilities were in-
cluded. For the qualitative part, due to logistical con-
straints a proportional sample of 20 out of 46 clinics
supported through BHOMA were chosen for facility
audits (10 in Chongwe, 7 in Kafue, 3 in Luangwa).
Clinics were stratified by district, and ranked according
to percent of total visits with a missing blood pressure
(BP) measurement. The top and bottom quarter were
chosen to represent the best performing and worst per-
forming clinics. At each clinic, one healthcare provider
who staffed the outpatient department was chosen for
an in-depth interview.
Data collection
Routine clinical data on patient demographics, BP mea-
surements, diagnosis, physical exam, lab tests, medica-
tion prescription and visits dates were extracted from
the EMR. For the qualitative component, facility audits
focusing on available equipment, medication stocks and
staffing were conducted as part of routine visits by
trained members of the BHOMA Quality Improvement
teams at half of the clinics, once during March-April
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care providers and a representative from the central
medication distribution agency in Zambia, Medical
Stores Limited, were also completed during these rou-
tine visits. Interviews were conducted by bilingual study
staff in English or a local language (Nyanja), depending
on the preference of the interviewee. Interviews were
recorded, transcribed and translated to English if
necessary.
Data analysis
Based on the available literature and data [11–13, 18],
we generated process and outcome indicators for
hypertension management in the rural African context
along the continuum of care: screening, diagnosis,
monitoring, treatment, follow up and BP control.
Although based on indicators developed in North
America and Europe, the ones presented here are
modified for low resource settings. The indicators in-
cluded: percentage of all visits with BP measurements;
percentage of visits by hypertensive patients with
hypertension diagnosis recorded in the chart; percent-
age of visits by hypertensive patients with physical
exam or urinalysis; percentage of visits by hyperten-
sive patients with at least one medication; number of
total visits by hypertensive patients; and percentage of
hypertensive patients with BP control. A target of
80% for process indicator percentages was used.
To view change over time, process indicators were cal-
culated as proportions across clinics, plotted by time
since intervention start. The time since intervention
start is the difference between the date of the visit and
the date the BHOMA intervention started at the clinic,
in 6 month intervals. Although the main units of ana-
lysis were “visits” for process indicators (each 6 month
interval only includes visits in that time period), we were
also interested in examining patients (each 6 month
interval includes all cumulative people up to that time
period), which required classifying people as either
hypertensive, or not. Because patients made different
numbers of clinic visits (and thus have different num-
bers of BP recordings), all BP measurements were
collapsed into a single median BP measurement per per-
son to capture the average for classification purposes.
Median was chosen over mean to minimize outlier
impact from “white coat hypertension”. A person was
classified as having hypertension if their median SBP
≥140 mmHg, or median DBP ≥90 mmHg, or if they
were ever on antihypertensive medication. For the out-
come indicator on BP control, in each 6 month interval
the hypertension classification was recalculated to
accommodate data from new visits. Only hypertensive
patients with at least 2 visits were included, with
categorization as “controlled” if their SBP <140 mmHgand DBP <90 mmHg at the most recent visit. All
analyses were conducted in Stata/SE 13.1 (StataCorp,
College Station, TX).
Based on these results, the qualitative in-depth inter-
view guide was developed to detail possible mechanisms
behind the quantitative data. Questions focused on the
theoretical knowledge and actual practice surrounding
screening, monitoring and treatment of hypertension at
the clinics. In addition, quantitative results were pre-
sented to interviewees to elicit possible mechanisms
behind the data. Thematic content analysis of the inter-
view transcripts was conducted by two authors in itera-
tive steps. After preliminary transcript review, a set of
codes representing similar ideas or themes was devel-
oped. Using NVIVO 10, transcripts were coded by the
two authors, with periodic comparisons and any coding
conflicts resolved through discussion. During each
round, any new concepts or emerging themes were
created into new codes, and applied to all transcripts.
Selected illustrative quotations are presented here.
Results
From Jan 2011 to Dec 2014, a total of 1,021,530 total
visits were made at the primary care clinics, with
318,380 visits (31.2%) made by adults ≥ 25 years. These
visits, which include repeat visits, constituted our main
quantitative analysis group. Of these, 62,543 visits
(20.6%) with hypertension were recorded, made by
26,363 people.
Most health facilities had either a nurse or clinical offi-
cer serve as the clinic in-charge (16/20), with 3/20
staffed by an environmental health technician (a non-
clinically trained cadre), and one clinic with only a
security guard present on the interview day. All except 2
facilities had a working BP machine, with 10/20 digital
and 13/20 analog. The average time to restock common
medications in all clinics was less than 1 month.
Hypertension screening and diagnosis
When plotted by time since intervention start, the
process indicator for screening (percent of total visits
with BP measurement) ranged from 65 to 90%, with
large variation between clinics (Fig. 1). Smaller clinics,
and facilities located in Luangwa district, were more
likely to consistently meet the target of 80%. Across
time, all clinics had their highest percentages in the first
year after intervention start.
Figure 2 shows the cascade diagram of hypertensive
patients from elevated BP measurement to normal BP at
a follow up visit. The proportion of visits by hyperten-
sive patients with recorded diagnosis was very low
(19.1% overall). The proportion was lower for males than
females (13.9% vs 21.9%, p < 0.0001), and did not appre-
ciably increase with time (Fig. 3).
Fig. 1 Screening process indicator: Percent of all visits with blood pressure measured, by time from intervention
Yan et al. BMC Health Services Research  (2017) 17:111 Page 4 of 10In the in-depth interviews, healthcare providers dem-
onstrated strong knowledge of screening guidelines (BP
taken at every visit as routine vital sign). In explaining
the decreasing trend of visits with BP measurement,
providers cited practical difficulties— principally equip-
ment and personnel shortages:
Some of the challenges include the BP machines,
they are not properly functional and the other
challenge at times is the personnel, in terms
of us the trained personnel, we are usually
overwhelmed. (provider at Chiawa clinic,
in Kafue district)
Analog and digital BP machines were used. Broken ma-
chines and batteries were difficult to replace, as clinic sup-
ply budgets were insufficient and erratic for needed
resources. Indeed, 2/20 clinics did not have a functioning
machine onsite during the time of the audit. Providers also
stated the clinic support workers who usually take vital
signs are insufficiently trained and are not able to useFig. 2 Cascade diagram of patients in rural primary care clinics, Zambiaanalog machines, which require use of stethoscopes. Insuf-
ficient and poorly motivated personnel constituted the
other major challenge, described by half of clinics.
Reasons for low proportions of hypertension diagnoses
were multifold. While most providers correctly identified
a DBP ≥90 mmHg as hypertensive, there was more vari-
ation in the reported SBP threshold for hypertension clas-
sification (120–150 mmHg). Another important theme
was the need for repeat visits of elevated BP before mak-
ing a formal diagnosis of hypertension (range of 2–4 mini-
mum visits). Lastly, there was a widespread belief among
healthcare providers that stress was a common transient
cause of elevated BP, and needed to be ruled out:
Sometimes one can give a high reading due to
circumstances, maybe stress, maybe some other
happenings in day to day life…We can ask such
a patient to be coming at regular intervals, maybe
on daily basis for a week or so for us to say this
is a confirmed case of hypertension. (provider at
Chilanga clinic, in Kafue district)
Fig. 3 Diagnosis process indicator: Proportion of visits by hypertensive patients with recorded diagnosis, by time from intervention start
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To assess hypertension monitoring, Table 1 shows the
proportion of visits by hypertensive patients with either a
recorded physical examination or urinalysis. Physical
examination included either a head and neck exam, a car-
diovascular exam or a neurological exam. Both process in-
dicators were consistently low at <10% across time.
Healthcare providers demonstrated limited knowledge
about the complications and comorbidities associated with
hypertension. The most commonly mentioned complica-
tion was retinopathy, at 7 out of 20 providers. In practice,
diabetes mellitus and renal failure are almost never evalu-
ated at the primary care level due to lack of supplies:
Because urinalysis testing was one of the routine
procedures in any given institution. But as time went
by, those things were no longer available…So, now I
don’t know whether the government is going poorer
and poorer to buy these urinalysis bottles for us, or to
buy these urine sticks for us. We don’t have. So us as
health workers, we work according to what we have.Table 1 Monitoring process indicator: Proportion of visits by







6 5.4% (727/13393) 0.16% (22/13393)
12 5.5% (754/13619) 0.17% (23/13619)
18 6.1% (688/11277) 0.07% (8/11277)
24 7.2% (591/8168) 0.04% (3/8168)
30 6.8% (453/6665) 0.03% (2/6665)
36 5.4% (278/5140) 0.08% (4/5140)
42 5.2% (191/3668) 0.05% (2/3668)
48 5.1% (31/613) 0% (0/613)
Total 6.0% (3682/61930) 0.1% (64/61930)What we don’t have, less work. (provider at Kasenga
clinic, in Chongwe district)
The interview with a representative of the central
medical distribution agency in Zambia revealed a urin-
alysis stick shortage for the past 5 years. The limited
amount of available supplies is largely reserved for preg-
nant women to check for preeclampsia, and for patients
initiating antiretroviral therapy.
When presented with the physical exam process indi-
cator, a third of health care providers were genuinely
surprised. In trying to explain the data, providers sug-
gested that the combination of too few properly trained
staff combined with the time pressure of a busy clinic
resulted in a tendency to focus solely on the patient’s
presenting complaint:
The number of people that you would be
expecting, so you just go direct on the real
complaint of the patient, not like maybe you
start checking from head to toe and the like.
So sometimes when you look at the queue,
“When am I going to finish with these people”.
Why am I examining the whole body when
I know what the patient is presenting with.
(provider at Kanakantapa clinic, in Chongwe
district)
Hypertension treatment and control
Overall, 21.1% of visits by patients with hypertension
had a prescribed antihypertensive medication. The pro-
portion of visits by hypertensive patients on an antihy-
pertensive drug, starts at 21.4% at 6 months after
intervention start, and decreases slightly over time to
15.7% at 48 months (Additional file 1: Table S1).
The most commonly prescribed antihypertensive med-
ications at visits by people with hypertension in the
Table 2 Antihypertensive drug and supply stocks related to hypertension management in rural primary care clinics, Zambia
Clinics (n = 20)
Drugs and Supplies Usually Provides Available today Average available number
of units per clinica
Stockout in last 6 mos
n (%)
Atenelol 9 (45%) 3 (15%) 100 16 (80%)
Enalapril 0 0 0 20 (100%)
Furosemide 15 (75%) 10 (50%) 524 9 (45%)
Hydralazine 2 (10%) 2 (10%) 1 19 (95%)
Hydrochlorothiazide 0 0 0 20 (100%)
Hydrochlorothiazide-amiloride 9 (45%) 5 (25%) 226 15 (75%)
Methyldopa 7 (35%) 4 (20%) 100 14 (70%)
Nifedipine 17 (85%) 6 (30%) 35 15 (75%)
Propranolol 6 (30%) 2 (10%) 35 18 (90%)
Spironolactone 0 0 0 20 (100%)
glucometer strips 2 (10%) 0 0 20 (100%)
urinalysis sticks 11 (55%) 8 (40%) 35 13 (65%)
a rounded to nearest whole number
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Table 2 illustrates the antihypertensive drug stocks found
at the 20 clinics surveyed in the facility audit, which differs
from WHO recommended therapy for hypertension in de-
veloping countries [19]. Nifedipine (17/20), furosemide
(15/20), hydrochlorothiazide-amiloride (known as Mod-
iuretic) (9/20), and atenolol (9/20) were the most com-
monly available drugs. Furosemide had the highest
availability at an average of 524 pills per clinic. Stockouts
in the last 6 months were common.
Among people with hypertension who made at least 2
visits, blood pressure control started at 12.9% at 6 months
after intervention start, and gradually plateaued at around
25% (Fig. 4). Because each 6 month interval includes all
cumulative people up to that time point, while the overallFig. 4 Blood pressure control outcome indicator: Percent of all hypertensiv
from interventionpercent of controlled hypertensives increased, the rate of
that change did not. In interviews, healthcare providers
displayed varied knowledge levels about hypertension
treatment. For initial treatment, half mentioned lifestyle
changes (reduction in salt intake, exercise), while the other
half started with drugs. First line medication preference
was heterogeneous, with 10/20 listing furosemide, 10/20
nifedipine and 5/20 hydrochlorothiazide-amiloride. Rec-
ommended first line medication by the Zambian Ministry
of Health is nifedipine or hydrochlorothiazide-amiloride
[20]. The majority of providers opted to refer hypertensive
patients who, after first line medication, were still uncon-
trolled at a follow up visit.
Stockouts and drug availability were reported to
greatly influence antihypertensive drug prescription.e people with at least 2 visits who achieved BP < 140/90, by time
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used, despite not being a recommended first line drug, a
provider explained:
The reason is simple…We know in place of Lasix we
should give Modiuretic, but we go ahead and give
these Lasix even without slow K because that’s what
we have at that particular time. We have ordered for
Modiuretic several times, it has never come through.
So we try, we outweigh, which one outweighs the other.
If I was to give Lasix, for this person with 200+ BP,
I give this person Lasix, or I let this patient go
on—which one? (provider at Mphuka clinic, in
Luangwa district)
Furosemide is also provided in much larger containers
(up to 1000 pills) than any other antihypertensives (up
to 100). Inconsistent antihypertensive drug stock was
mentioned by every provider, even though many are on
the essential drug list and are in stock at the central dis-
tribution agency. The interview with the Medical Stores
Limited representative revealed two potential reasons for
this: 1) incorrect ordering of drugs by the clinic on their
paper based forms, and 2) no transport to deliver
ordered drugs from the District Medical Office to the
clinic.
Follow ups and provider preparedness
A common challenge noted in all interviews was poor
visit attendance. Over half of hypertensive patients pre-
sented only once to clinics during the 4-year study
period (Fig. 5).
Patients are being encouraged to be coming for
checkups…But then sometimes because of distance,
the patients won’t be coming for regular checkups.
They prefer coming when they’re feeling bad, butFig. 5 Number of visits by hypertensive patients presenting to rural primarwhen all is well, they wouldn’t come because they
would look “Ah, just for a checkup, all that long,
all that far.” (provider at Kanakantapa clinic, in
Chongwe district)
Providers believed that hypertension was not recog-
nized or prioritized by the community, as a largely
asymptomatic disease, with far distances contributing to
the problem of nonattendance.
Another theme affecting care was self-reported pro-
vider preparedness with managing hypertension. Most
healthcare providers stated they felt prepared to screen,
manage and treat hypertension and other non-
communicable diseases; however, half spontaneously
listed furosemide as a first line drug.
Discussion
Although the formal evaluation for BHOMA across
disease entities is ongoing, this analysis of site data
reveals important data about hypertension. Across
these primary care clinics, despite high screening
rates for hypertension, the process indicators for diag-
nosis, monitoring and treatment were poor and did
not improve over time. The largest drop-offs in the
cascade from elevated BP to controlled hypertensive
appear to be lack of follow up visits and providers
not formally diagnosing patients to initiate treatment.
For BP control among hypertensive patients who
made at least 2 visits (a small subset), while there
was an increase in the overall cumulative percent, the
rate of change did not increase. From qualitative in-
terviews, challenges to hypertension management
from the provider side included drug stock outs, lack
of equipment, lack of knowledge despite reported
self-confidence, and difficulty in getting patients to
return for follow up visits. While BHOMA does in-
corporate process indicators into its multi-prongedy care facilities, Zambia
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hypertension screening. The overall modest improve-
ment suggests that despite initial strong efforts, the
BHOMA intervention was not successful in overcom-
ing these barriers for hypertension control.
A major limitation of this study is the lack of veri-
fied process and outcome indicators to use for evalu-
ating hypertension care in developing countries,
because most quality improvement indicators are
created nationally by developed countries. While the
screening, physical exam and diagnosis process indica-
tors were compared to a target of 80%, the remaining
indicators did not have an obvious standard (e.g., pro-
portion of visits by hypertensive patients with urinaly-
sis, or on treatment) [18]. These latter indicators are
more dependent on clinical judgment and will require
more extensive external review to determine appropri-
ate targets. Other limitations include insufficient data
on patient characteristics (ie smoking, educational
level) to build logistic regression models to predict
the likelihood of successful management. Patient com-
pliance with visits or medications was also not
assessed. For the qualitative data, social desirability
bias may have been present in interviews. Further-
more, we only interviewed providers and did not seek
patient perspectives on hypertension management.
Our findings are consistent with data from other
developing countries. Given the BHOMA clinics repre-
sent almost all rural government facilities in Lusaka
province, they are likely very representative of the
Zambian population in particular, and perhaps rural
southern African populations in general. The rapid
drop-off from patients with elevated BP to formally diag-
nosed as hypertensive was consistent with data from the
SAGE study in middle income countries, that showed
among the hypertensive population, 66% were undiag-
nosed before the survey, with 73% untreated, and 90%
uncontrolled [21]. As other surveys in low and middle
income countries have shown, health care providers may
not know the proper treatment for hypertension, and
prescription patterns are seldom evidence based [22].
For example in our study, like in other low income con-
texts, thiazides were not commonly used despite being
cheap and available [23]. In terms of sporadic care, as
our data showed, patients may not think of hypertension
as an important disease that needs regular follow up,
with lack of symptoms as one of the most common rea-
sons reported for not attending scheduled visits [24, 25].
Lastly, our finding that most providers in the clinics feel
prepared to manage hypertension contrasted with the
findings of the Zambia National Healthcare Strategic
Plan, which states 50.7% of healthcare providers do not
feel adequately prepared to manage hypertension in pri-
mary care settings [26]. Bias may have affected ourinterviews as admitting discomfort with hypertension
management could be seen as tantamount to admitting
incompetence.
Strong primary care systems have been shown to im-
prove health [4]. In the US, geographical areas with
higher primary care provider ratios to the population,
but not higher specialist ratios, are associated with lower
all-cause mortality and lower mortality from cardiovas-
cular disease, cancer and stroke [27, 28]. However, there
remain great difficulties in implementing evidence-based
primary care interventions, with new research findings
taking almost two decades to become widespread
practice [29].
The disappointing data from the retrospectively
generated process and outcome indicators presented
here imply that a primary care quality improvement
program will not necessarily improve performance in-
dicator targets that are not explicitly pre-identified. In
developed countries, performance indicators have
been associated with greater likelihood of BP control
in hypertensive patients if based on explicit evidence
[11]. Furthermore, when coupled with financial incen-
tives, they may drive positive health outcomes on a
faster timeline, as in Rwanda where pay for perform-
ance since 2006 has increased institutional delivery,
tetanus vaccine coverage and attendance at pediatric
preventive care visits [5, 10, 30]. The data from this
study is an important first step in developing
Zambian appropriate targets for chronic non-
communicable diseases. Additional file 2: Table S2
presents the structure, process and outcome indica-
tors relevant for hypertension management, challenges
and possible solutions.
Future research questions include patient and com-
munity member perspectives on non-communicable
disease care, verifying quality improvement indicators
and target standards that are relevant for hyperten-
sion in low resource settings, and evaluating pay for
performance schemes to address challenges. The
complete evaluation of BHOMA’s impact on commu-
nity mortality and morbidity is ongoing with commu-
nity surveys, and will elucidate if BHOMA has
managed to improve community outcomes, even if
the intermediate structure and process indicators for
hypertension have not shown progress.Conclusions
In conclusion, this analysis presents data on process and
outcome indicators for hypertension management in pri-
mary care clinics enrolled in the BHOMA study. While
the screening process indicator was initially high, over
time it decreased. Process indicators for diagnosis, moni-
toring and treatment were low overall and did not show
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blood pressure control did increase, but the rate of
change did not. Challenges to hypertension management
included supply stock outs, lack of knowledge and
patient nonattendance at return visits.
Additional files
Additional file 1: Table S1. Treatment process indicator: Proportion of
visits by hypertensive patients with antihypertensive medication
prescribed in rural primary care clinics, Zambia (DOCX 13 kb)
Additional file 2: Table S2. Challenges to hypertension management
in rural primary care clinics, Zambia (DOCX 17 kb)
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